General form of registration statement for all companies including face-amount certificate companies

Note 5 - Cash, Cash Equivalents and Investments 1 (Tables)

v3.24.4
Note 5 - Cash, Cash Equivalents and Investments 1 (Tables) - Pieris Pharmaceuticals, Inc. [Member]
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Notes Tables    
Cash, Cash Equivalents and Investments [Table Text Block]
   

Total

   

Quoted prices in active markets (Level 1)

   

Significant other observable inputs (Level 2)

   

Significant unobservable inputs (Level 3)

 

September 30, 2024

                               

Money market funds, included in cash equivalents

  $ 11,893     $ 11,893     $     $  

Total

  $ 11,893     $ 11,893     $     $  
   

Total

   

Quoted prices in active markets (Level 1)

   

Significant other observable inputs (Level 2)

   

Significant unobservable inputs (Level 3)

 

December 31, 2023

                               

Money market funds, included in cash equivalents

  $ 13,224     $ 13,224     $     $  

Investments - US treasuries

    8,970       8,970              

Total

  $ 22,194     $ 22,194     $     $  
   

Total

   

Quoted prices in active markets (Level 1)

   

Significant other observable inputs (Level 2)

   

Significant unobservable inputs (Level 3)

 

December 31, 2023

                               

Money market funds, included in cash equivalents

  $ 13,224     $ 13,224     $     $  

Investments - US treasuries

    8,970       8,970              

Total

  $ 22,194     $ 22,194     $     $  
   

Total

   

Quoted prices in active markets (Level 1)

   

Significant other observable inputs (Level 2)

   

Significant unobservable inputs (Level 3)

 

December 31, 2022

                               

Money market funds, included in cash equivalents

  $ 17,618     $ 17,618     $     $  

Investments - US treasuries

    3,573       3,573              

Investments - Foreign treasuries

    896       896              

Investments - Asset-backed securities

    499             499        

Investments - Corporate bonds

    15,566             15,566        

Total

  $ 38,152     $ 22,087     $ 16,065     $  
Debt Securities, Available-for-Sale [Table Text Block]  
   

Contractual maturity

                                 
   

(in days)

   

Amortized Cost

   

Unrealized gains

   

Unrealized losses

   

Fair Value

 

Investments

                                       

US treasuries

    4-51     $ 8,969     $ 1     $     $ 8,970  

Total

          $ 8,969     $ 1     $     $ 8,970